Your SlideShare is downloading. ×
Global life sciences agenda2011
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Global life sciences agenda2011

467
views

Published on

Published in: Education, Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
467
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. To access the audio webcast: Go to www.ibb.ubs.com/Conferences. Look for the webcast link to the right of theGlobal Life Sciences Conference Global Life Sciences Conference. Please note: Only companies who have chosen to webcast will be listed. Breakout session to follow immediately after presentation, unless otherwise noted. Each session will last 30 minutes.Monday, September 19, 2011MeetingRoom Ballroom III Ballroom II Ballroom IV Ballroom I Ballroom VBreakout Broadway, Conference Level Julliard, Conference Level Carnegie, Conference Level Uris, Conference Level Alvin, Conference LevelRoom7:00 a.m. Registration and continental breakfast7:45 Welcome remarks Robert Digia, Global Head of Healthcare Investment Banking, UBS Investment Bank8:00 Cumberland Pharmaceuticals Inc. Immunomedics, Inc. AMAG Pharmaceuticals OraSure Technologies Onconova Therapeutics, Inc. Martin Cearnal, Senior Vice President Cynthia Sullivan, President & CEO Brian Pereira, Chief Executive Officer Douglas Michels, President & CEO Ramesh Kumar, President & CEO & Chief Commerical Officer Frank Thomas, Chief Financial Officer8:30 Valeant Pharmaceuticals International, Inc. Bio-Rad Laboratories, Inc. Exelixis MorphoSys AG Rajiv De Silva, President & COO, Specialty Norman Schwartz, President & CEO Michael Morrissey, Chief Executive Officer Simon Moroney, Chief Executive Officer Pharmaceuticals Christine Tsingos, Chief Financial Officer Claudia Gutjahr-Loser, Head of Corporate Communication & IR9:00 Agilent Technologies, Inc. Haemonetics Corporation Acorda Therapeutics Galapagos NV Progenics Pharmaceuticals, Inc. Nick Roelofs, President, Life Sciences Group Chris Lindop, Chief Financial Officer & VP Business Ron Cohen, MD, President & CEO Guillaume Jetten, Chief Financial Officer Mark Baker, Chief Executive Office Development9:30 Regeneron Pharmaceuticals, Inc. CONMED Corporation Dexcel Pharma STRATEC Biomedical AG Syneron Medical Ltd. Michael Aberman, Vice President, Strategy Joseph Corasanti, President & CEO Dan Oren, President & CEO Marcus Wolfinger, Chief Executive Officer Louis Scafuri, Chief Executive Officer & Investor Relations10:00 Illumina Onyx Pharmaceuticals Coloplast A/S Array BioPharma Inc. China Cord Blood Corporation Jay Flatley, President & CEO Warren DeSouza, Vice President, Finance Lars Rasmussen, President & CEO Robert Conway, Chief Executive Officer Albert Chen, Chief Financial Officer Joseph Leveque, Vice President, Medical & Scientific Affairs10:30 Pharmasset West Pharmaceutical Services, Inc. Questcor Pharmaceuticals, Inc. Natus Medical Incorporated Albany Molecular Research, Inc. Schaefer Price, Chief Executive Officer Donald Morel, Chairman & CEO Don Bailey, President & CEO Jim Hawkins, Chief Executive Officer Mark Frost, Chief Financial Officer Richard Smith, Vice President William Federici, Chief Financial Officer11:00 Thermo Fisher Scientific Bio-Reference Laboratories, Inc. ArQule, Inc. Lannett Company, Inc. Benvenue Medical, Inc. Pete Wilver, Senior Vice President & CFO Marc Grodman, MD, Chairman, President & CEO Paolo Pucci, Chief Executive Officer Arthur Bedrosian, President & CEO Robert Weigle, Chief Executive Officer Peter Lawrence, President & COO Martin Galvan, Chief Financial Officer Brian Schwartz, Chief Medical Officer11:30 Biogen Idec Sirona Dental Systems, Inc. Ablynx NV Spectrum Pharmaceuticals, Inc. PowerVision, Inc. Paul Clancy, Executive Vice President & CFO Jost Fischer, Chairman & CEO Edwin Moses, Chairman & CEO Rajesh Shrotriya, Chief Executive Officer Barry Cheskin, President & CEO John Sweeney, Vice President, Investor Relations12:00 p.m. Sigma-Aldrich BioScrip, Inc. Optimer Pharmaceuticals Vical Incorporated Tetraphase Pharmaceuticals, Inc. Rakesh Sachdev, President & CEO Richard Smith, President & CEO Pedro Lichtinger, President & CEO Vijay Samant, President & CEO Guy Macdonald, President & CEO Sondra Brown, Director, Investor Relations MJ Graves, Interim Chief Financial Officer12:00 Lunch - Boxed lunches will be available12:30 Celgene Corporation Meridian Bioscience, Inc. ALK-Abello A/S Trauson Holdings Robert Hugin, Chairman & CEO Jack Kraeutler, Chief Executive Officer Per Plotnikof, Director Investor Relations Ken Liu, Director of Investor Relations Charles Wang, Chief Financial Officer1:00 Bruker Corporation Dyax Corp. Unilife Corporation PDI, Inc. Concord Medical Services Holdings Limited Frank Laukien, President & CEO Gustav Christensen, President & CEO Alan Shortall, Chief Executive Officer Nancy Lurker, Chief Executive Officer Jianyu Yang, President & CEO Steve Sun, Co-Chairman & CFO1:30 Warner Chilcott Isis Pharmaceuticals, Inc. Amicus Therapeutics Tengion, Inc. Chiasma, Inc. Paul Herendeen, Executive Vice President & CFO B. Lynne Parshall, Chief Operating Officer & CFO John Crowley, Chairman & CEO Brian Davis, Chief Financial Officer & VP, Finance Fredric Price, President & CEO2:00 PerkinElmer, Inc. Basilea Pharmaceutica International Ltd. Infinity Pharmaceuticals China Biologics Robert Friel, Chairman & CEO Ron Scott, Chief Financial Officer Adelene Perkins, President & CEO Tristan Kuo, Chief Financial Officer2:30 Incyte Corp. RainDance Technologies MagForce AG PolyMedix, Inc. Flamel Technologies Paul Friedman, MD, President & CEO Roopom Banerjee, President & CEO Peter Heinrich, Chief Executive Officer Nicholas Landekic, President & CEO Stephen Willard, Chief Executive Officer3:00 Glenmark Generics Healthpoint Biotherapeutics Theratechnologies DURECT Corporation Avila Therapeutics, Inc. Terrance J. Coughlin, Chief Executive Officer Travis Baugh, President & COO John-Michel Huss, President & CEO Matt Hogan, Chief Financial Officer Katrine Bosley, Chief Executive Officer Rob Bancroft, Executive Vice President, Strategic & Commercial Development3:30 Cubist Pharmaceuticals Sequenom, Inc. Alnylam Pharmaceuticals, Inc. Evolva TYRX, Inc David McGirr, Senior Vice President & CFO Ron Lindsay, Director, EVP of Research John Maraganore, Chief Executive Officer Neil Goldsmith, Chief Executive Officer Robert White, President & CEO & Development4:00 H. Lundbeck A/S Mersana Therapeutics, Inc. Impulse Dynamics Syndax Pharmaceuticals, Inc. Sinovac Biotech Palle Holm Olesen, Chief Specialist, Investor Relations Nicholas Bacopoulos, President & CEO Daniel Burkhoff, Chief Medical Officer Robert Goodenow, PhD, Chief Business Officer Weidong Yin, President & CEO Nan Wang, Interim Chief Financial Officer4:30 AVEO Pharmaceuticals, Inc. Cutera, Inc. Hutchison Medi Pharma Vitae Pharmaceuticals, Inc. Tuan Ha-Ngoc, President & CEO Kevin Connors, Chief Executive Officer Mark Lee, Vice President, Corporate Finance Jeff Hatfield, President & CEO & Development5:30 p.m. Business sessions conclude-
  • 2. To access the audio webcast: Go to www.ibb.ubs.com/Conferences. Look for the webcast link to the right of theGlobal Life Sciences Conference Global Life Sciences Conference. Please note: Only companies who have chosen to webcast will be listed. Breakout session to follow immediately after presentation, unless otherwise noted. Each session will last 30 minutes.Tuesday, September 20, 2011MeetingRoom Ballroom III Ballroom II Ballroom IV Ballroom I Ballroom VBreakout Broadway, Conference Level Julliard, Conference Level Carnegie, Conference Level Uris, Conference Level Alvin, Conference LevelRoom7:00 a.m. Registration and continental breakfast in Ballroom Foyer, Ballroom Level7:30 Impax Laboratories Arthrocare Corporation Myrexis, Inc. AcelRx Pharmaceuticals, Inc. Reva Medical, Inc. Art Koch, Executive Vice President & CFO Todd Newton, Senior Vice President & CFO Robert Lollini, President & CEO Richard King, President & CEO Bob Stockman, Chairman & CEO8:00 Life Technologies ResMed Endologix, Inc. PDL BioPharma Fluidigm Corporation Gregory Lucier, Chairman & CEO David Pendarvis, Chief Administrative Officer John McDermott, President & CEO John McLaughlin, President & CEO Vikram Jog, Chief Financial Officer Christine Larson, Vice President & CFO Un Kwon-Casado, Director, Strategic Marketing William Craumer, Investor Relations8:30 Amgen Tecan Group AG Sagent Pharmaceuticals Simcere Pharmaceutical Group QLT Inc. Roger M. Perlmutter MD, PhD, Executive Vice Rudolf Eugster, Chief Financial Officer Jeffrey Yordon, Chief Executive Officer Yehong Zhang, President Robert Butchofsky, President & CEO President, Research & Development Martin Braendle, Head of Corporate Communications Ronald Pauli, Chief Financial Officer & Investor Relations9:00 Bayer AG Pall Corporation Ardea Biosciences, Inc. Neurocrine Biosciences, Inc. Symphogen Dr. Marijn Dekkers, Chief Executive Officer Lisa McDermott, Treasurer & CFO Barry Quart, President & CEO Kevin Gorman, President & CEO Kirsten Drejer, Chief Executive Officer Stephen Davis, Executive Vice President & COO9:30 Jazz Pharmaceuticals, Inc. Align Technology, Inc. OncoGenex Pharmaceuticals, Inc. ProteinSimple (fmr. Cell Biosciences) PROLOR Biotech, Inc. Bruce Cozadd, Chairman & CEO Kenneth Arola, Vice President, Finance & CFO Michelle Burris, Executive Vice President, Operations Tim Harkness, President & CEO Abraham Havron, Chief Executive Officer Kate Falberg, Chief Financial Officer & CFO Ami Knoefler, Executive Director, Investor Relations & Corporate10:00 Medicis Pharmaceutical Corporation Nektar Therapeutics Luminex Corp. YM Biosciences Foamix Ltd. Jason Hanson, Executive Vice President & COO Howard W. Robin, President & CEO Patrick Balthrop, President & CEO Nick Glover, President & CEO Dov Tamarkin, Chief Executive Officer10:30 Gilead Sciences, Inc. Abaxis, Inc. Algeta ASA PAION AG VBL Therapeutics Kevin Young CBE, Executive Vice President, Clint Severson, Chairman, President & CEO Andrew Kay, President & CEO Wolfgang Soehngen, Chief Executive Officer Dror Harats, Chief Executive Officer Commercial Operations11:00 DENTSPLY International Inc. BTG plc Given Imaging Ltd. Keryx Biopharmaceuticals, Inc. Pacira Pharmaceuticals, Inc. William Jellison, Senior Vice President & CFO Andy Burrows, Director of Investor Relations Homi Shamir, President & CEO Ron Bentsur, Chief Executive Officer David Stack, President & CEO * No breakout11:30 Teva Pharmaceutical Industries Ltd. Grünenthal Group Cadence Pharmaceuticals, Inc. Avanir Pharmaceuticals, Inc. Cellectis William Marth, President & CEO, Teva Pharmaceuticals Harald F. Stock, Chief Executive Officer Ted Schroeder, President & CEO Keith Katkin, President & CEO David Sourvive, Executive Vice President, Americas Corporate Development12:00 p.m. Cepheid Pharmacyclics Cynosure Response Genetics Fibrocell Science, Inc. Andrew Miller, Chief Financial Officer Joe Buggy, Vice President of Research Michael Davin, President, CEO & Chairman of the Board Denise McNairn, Chief Executive Officer David Pernock, Chairman & CEO Timothy Baker, Executive Vice President & CFO Christine Meda, President Declan Daly, Chief Financial Officer David OToole, Chief Financial Officer12:00 Lunch - Boxed lunches will be available12:30 Novo Nordisk BioMarin Pharmaceutical, Inc. Symmetry Medical, Inc. Vanda Pharmaceuticals Inc. Saladax Biomedical Alan Moses, Chief Medical Officer Steve Aselage, Chief Business Officer Tom Sullivan, Chief Executive Officer Mihael Polymeropoulos, President & CEO Edward Erickson, President & CEO Jannick Lindegaard, Director, Investor Relations Fred Hite, Chief Financial Officer Jim Kelly, Chief Financial Officer Salvatore Salamone, PhD, Chief Scientific Officer Adrienne Choma, Esq, Vice President, Marketing & Sales1:00 Vertex Pharmaceuticals XenoPort, Inc. Merit Medical Systems, Inc. BioSpecifics Technologies Corp. Michael Partridge, Vice President, Investor Relations Ronald W. Barrett, Chief Executive Officer Fred Lampropoulos, Chairman & CEO Thomas L. Wegman, President1:30 Vectura Group plc Rigel Pharmaceuticals, Inc. Complete Genomics PhaseBio Pharmaceuticals, Inc. Cytokinetic Chris Blackwell, Chief Executive Officer Ryan Maynard, Chief Financial Officer Ajay Bansal, Chief Financial Officer Christopher Prior, PhD, Chief Executive Officer Robert Blum, President & CEO Kathryn Gregory, Vice President, Business Development2:00 Mylan, Inc. VIVUS, Inc. Regulus Therapeutics, Inc. Slate Pharmaceuticals Arstasis, Inc. John Sheehan, Chief Financial Officer Leland Wilson, Chief Executive Officer Garry Menzel, Chief Operating Officer & EVP, Finance Bob Whitehead, Chief Executive Officer Alexander Arrow, Chief Financial Officer Timothy Morris, Senior Vice President & CFO Neil Gibson, Chief Scientific Officer2:30 Seattle Genetics, Inc. Depomed, Inc. Zalicus, Inc. Intercell AG Harvard Bioscience, Inc. Eric Dobmeier, Chief Operating Officer James Schoeneck, President & CEO Mark Corrigan, Chief Executive Officer Thomas Lingelbach, Chief Executive Officer David Green, President Steve Greco, Vice President, Sales Justin Renz, Chief Financial Officer Abe Wischnia, Investor Relations Gina Nugent, Investor Relations Officer3:00 NxStage Medical, Inc. Auxilium Pharmaceuticals, Inc. Santarus, Inc. ForteBio, Inc. Medivance Jeffrey Burbank, Chief Executive Officer Will Sargent, Vice President, Investor Relations Gerald T. Proehl, President & CEO Joseph D. Keegan, President & CEO Robert Kline, President & CEO3:30 United Therapeutics Corporation Protalix BioTherapeutics Dynavax Cosmo Pharmaceuticals SpA Andy Fisher, Chief Strategic Officer David Aviezer, President & CEO Michael Ostrach, Chief Business Officer Chris Tanner, Chief Financial Officer Shari Annes, Investor Relations4:00 Qiagen N.V. Sunesis Pharmaceuticals, Inc. SkinMedica Immatics Biotechnologies GmbH Pluristem Therapeutics Inc. Roland Sackers, Chief Financial Officer Eric Bjerkholt, Senior Vice President, Corporate Mary Fisher, Chief Executive Officer Paul Higham, Chief Executive Officer Zami Aberman, Chairman & CEO Development & Finance4:30 Micromet, Inc. Accuray, Inc. Radius Health, Inc. Anadys Pharmaceuticals, Inc. Christian Itin, President & CEO Euan Thomson, President & CEO Rich Lyttle, President & CEO Stephen Worland, PhD, President & CEO5:30 p.m. Business sessions conclude
  • 3. To access the audio webcast: Go to www.ibb.ubs.com/Conferences. Look for the webcast link to the right of theGlobal Life Sciences Conference Global Life Sciences Conference. Please note: Only companies who have chosen to webcast will be listed. Breakout session to follow immediately after presentation, unless otherwise noted. Each session will last 30 minutes.Wednesday, September 21, 2011MeetingRoom Ballroom III Ballroom II Ballroom IV Ballroom I Ballroom VBreakout Broadway, Conference Level Julliard, Conference Level Carnegie, Conference Level Uris, Conference Level Alvin, Conference LevelRoom7:00 a.m. Registration and continental breakfast in Ballroom Foyer, Ballroom Level7:30 Sangamo BioSciences, Inc. Astex Pharmaceuticals (fka SuperGen) Zogenix, Inc. Idera Pharmaceuticals, Inc. GlobeImmune, Inc. Edward Lanphier, President & CEO James Manuso, Chairman & CEO Stephen J. Farr, President & COO Sudhir Agrawal, D. Phil., Chairman & CEO Timothy Rodell, President & CEO Ann Rhoads, Chief Financial Officer8:00 SciClone Zealand Pharma A/S GI Dynamics Baxano, Inc. Gary Titus, Senior Vice President & CFO Mats Blom, Senior Vice President & CFO Stuart Randle, Chief Executive Officer Anthony Recupero, President & CEO8:30 Baxter International The Medicines Company Evotec AG Osiris Therapeutics, Inc. Helsinn Healthcare SA Bob Hombach, Corporate Vice President & CFO Clive Meanwell, Chairman & CEO Werner Lanthaler, Chief Executive Officer C. Randal Mills, PhD, President & CEO Riccardo Braglia, Chief Executive Officer9:00 Mettler-Toledo International, Inc. Greatbatch, Inc. Hansen Medical, Inc. Verastem, Inc. Kensey Nash Corp. William Donnelly, Chief Financial Officer Thomas Hook, President & CEO Bruce Barclay, President & CEO Christoph Westphal, Chairman Joe Kaufmann, President & CEO9:30 MAP Pharmaceuticals Ion Beam Applications SA Novatrans Group SA BioLineRx Exiqon A/S Timothy Nelson, President & CEO Jean-Marc Bothy, Chief Financial Officer Oren Sadiv, Chief Executive Officer Kinneret Savitsky, PhD, Chief Executive Officer Lars Kongsbak, Chief Executive Officer Philip Serlin, Chief Financial Officer & COO10:00 Cyberonics Medivation, Inc. Analogic Corporation Trevena, Inc. Seahorse Bioscience Dan Moore, President & CEO David Hung, MD, President & CEO Mike Levitz, Vice President, Treasurer & CFO Maxine Gowen, President & CEO Jay Teich, Chief Executive Officer Mark Namaroff, Director of Strategic Marketing & Investor Relations10:30 Endo Pharmaceuticals HeartWare International Affymetrix Clal Biotechnology Industries Geron Alan Levin, Chief Financial Officer Doug Godshall, President & CEO Frank Witney, Chief Executive Officer Ruben Krupik, Chief Executive Officer Stephen Kelsey, Executive Vice President, Ofer Gonen, Vice President Head of Research and Development & CMO11:00 Intuitive Surgical Pronova BioPharma Enobia Pharma Endosense SA Aposense Ltd. Aleks Cukic, Vice President, Strategy Hamed Brodersen, Vice President, Investor Relations Robert Heft, President & CEO Eric Le Royer, Chief Executive Officer Yoram Ashery, Chief Executive Officer Calvin Darling, Senior Director FPA & Investor Relations & Communications11:30 Human Genome Sciences, Inc. ZOLL Medical Corporation R-Pharm Genmab SIGA Technologies David Southwell, Chief Financial Officer Richard Packer, Chief Executive Officer Mikhail Samsonov, Chief Medical Officer Jan van de Winkel, President & CEO Eric Rose, MD, Chief Executive Officer12:00 p.m. Lunch - Boxed lunches will be available12:15 Keynote Discussion Senator Bill Frist, Former Majority Leader, United States Senate Governor Howard Dean, Former Governor of Vermont and Former Chair of the Democratic National Committee1:30 Allergan, Inc. ICU Medical, Inc. RTI Biologics Momenta Pharmaceuticals, Inc. GlycoVaxyn Jeffrey Edwards, Executive Vice President, Scott Lamb, Chief Financial Officer Brian Hutchison, President & CEO Rick Shea, Senior Vice President & CFO Philippe Dro, Chief Executive Officer Finance and Business Development & CFO Rob Jordheim, Chief Financial Officer2:00 Idenix Pharmaceuticals, Inc. BIOLASE Technology Macrocure Ltd. Acceleron Pharma Philogen Ron Renaud, President & CEO Federico Pignatelli, Chief Executive Officer Mitchell Shirvan, Chief Executive Officer John Knopf, Chief Executive Officer Eveline Bordoli-Trachsel, Scientific Consultant2:30 Alexion Pharmaceuticals, Inc. Alkermes Neovasc, Inc. Intuity Medical Pharming Group NV Leonard Bell, Chief Executive Officer James Frates, Chief Financial Officer Alexei Marko, Chief Executive Officer Emory Anderson, President & CEO Sijmen de Vries, Chief Executive Officer3:00 AVI BioPharma, Inc. IMRIS Inc. Aperion Biologics, Inc. Labcyte Inc. GenturaDx Chris Garabedian, President & CEO David Graves, Chief Executive Officer Daniel Lee, Chief Executive Officer Mark Fischer-Colbrie, President & CEO Mark Bagnall, President & CEO3:30 Amarin Golden Meditech Holdings Limited Regado Biosciences, Inc. Epigenomics AG Universal Biosensors Joseph Zakrzewski, Executive Chairman & CEO Samuel Kong, Chief Financial Officer Ellen McDonald, Senior Vice President Business Geert Walther Nygaard, Chief Executive Officer Paul Wright, Chief Executive Officer Karen Lau, Senior Manager, Head of Investor Relations Operations & CBO4:00 Tranzyme, Inc. Chimerix, Inc. D-Pharm Ventrus Biosciences Vipin Garg, President & CEO Kenneth Moch, President & CEO Alex Kozak, Chief Executive Officer Russell Ellison, Chairman & CEO5:00 p.m. Conference concludes